Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-11

Clinical Trial Update: Saffron and Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating saffron for ulcerative colitis is underway, with unspecified status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saffron (saffron extract)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Ulcerative Colitis | Phase 2 | Status: UNKNOWN